Since last September, the biotechnology industry’s funding has had outflows each month, which totaled $3 billion in January and February of this year. Funds raised by biotechnology companies have decreased 68.4% from 2015, falling from $58 billion to $18.3 billion. The Nasdaq Biotech Index of US health care firms has fallen 17.6% since the beginning […]
The world’s Total Primary Energy Supply for 2014 was 13,700 Mtoe, with 14% representing renewable energy sources. Of this percentage, solid biofuels/charcoal represented 66%, making it the largest global renewable energy source. Hydro power represented 18% of renewable sources, with geothermal sources, liquid biofuels, biogases, solar, wind and tide sources accounting for the remainder. Renewable […]
According to the Nature Index, which follows the research output of over 8,000 global institutions, the 10 countries with the highest increases, or weighted fractional count (WFC), in their scientific contributions from 2012 to 2015 are Saudi Arabia, increasing 87.1%; China, increasing 43.6%; Poland, increasing 34.3%; Russia, increasing 24.2%; India, increasing 23.0%; Brazil, increasing 18.9%; […]
In Chemical & Engineering News’ (C&EN) latest Global Top 50, the 50 largest chemical firms surveyed brought in a combined $775.2 billion in sales in 2015, a 10.8% decrease. However, profits increased 15.1%, or $96.7 billion, and profit margins climbed almost three percentage points to 13.5%, indicating that none of the 50 companies surveyed recorded […]
Earlier this month, the FDA issued a new draft guidance to educate drug and IVD sponsors on how to develop a therapeutic simultaneously with an IVD companion diagnostic. It includes information on how to obtain marketing authorization, regulatory requirements to consider, how to plan and perform clinical trials that involve IVD companion diagnostics, and administrative […]
Since the early 1990s, there has been a sharp decline of FDA approvals for antibiotics, as pharmaceutical companies ceased antibody development due to high costs and low returns. However, with numerous government incentives for fighting antimicrobial resistance, companies are beginning to renew interest in the field. A May-June survey of 18 biotechnology, pharmaceutical and diagnostics […]
Late last month, Vice President Joe Biden announced additions and changes to the Cancer Moonshot Task Force initiative. These include, but is not limited to, the National Cancer Institute (NCI) collaborating with 20–30 pharmaceutical and biotechnology firms to accelerate researchers’ access to data, “investigational agents” and approved drugs, with the first agents estimated to be […]
In 2015, total world primary energy consumption increased 1.0%, which is below the 10-year average growth rate of 1.9%. Of this increase, emerging economies accounted for 97% of the increase. Renewable power use continued to grow steadily, representing 3% of global primary energy consumption. The annual average oil price stabilized at $52.39/barrel, a 47% decline; […]
In June, the Centers for Medicare and Medicaid Services published its final rule for lab fee schedule changes. As with the proposal (see IBO 10/15/15), private rates for clinical lab diagnostic tests will be set according to the weighted median reported rates of private payors, with limitations. New to the final rule is the implementation […]
As pharmaceutical companies expand their presence in emerging regions’ middle-class markets, they are incorporating new categories of products, including large-molecule biologics (i.e., monoclonal antibodies), and new gene and cell therapies. The biologics market is forecast to jump to $278 billion by 2020, a 71.6% increase from 2014. According to a survey of 254 pharmaceutical executives, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
